Global X Genomics & Biotechnology ETF
Price through Oct 7, 2026 · Flows through Aug 23, 2024. Figures use the latest available records, not a live quote. Fund details retrieved Oct 7, 2026. Holdings snapshot retrieved Oct 7, 2026.
The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of genomic science and biotechnology, as well as applications thereof (collectively, "Genomics & Biotechnology Companies"), as defined by Solactive AG, the provider of the underlying index. The fund is non-diversified.
SOURCE: MARKET TAPE & DAILY CREATION/REDEMPTION RECORDS · 6M SHOWN
Recent fund-flow records are unavailable, while the price has returned +47.1% so far this year. At 0.50% a year it is not the cheapest way in — IWM has a reported fee of 0.19%.
COMPOSED FROM THE FUND’S OWN DAILY RECORDS · UPDATED WITH EACH REFRESH
CELL SIZE IS PORTFOLIO WEIGHT · COLOR IS THE CHANGE IN THE LATEST AVAILABLE SNAPSHOT · TOP 40 POSITIONS
| # | Holding | Weight | Price | Day | 52-wk | |
|---|---|---|---|---|---|---|
| 1 | MRNAMODERNA | 9.54% | $196.48 | +4.8% | ||
| 2 | TWSTTWIST BIOSCIENCE | 7.25% | $155.65 | -6.8% | ||
| 3 | TXG10X GENOMICS | 6.74% | $76.10 | -5.7% | ||
| 4 | ILMNILLUMINA | 5.93% | $267.76 | -2.1% | ||
| 5 | NTRANATERA | 5.45% | $395.56 | -1.3% | ||
| 6 | GHGUARDANT HEALTH | 5.39% | $168.33 | -1.4% | ||
| 7 | TECHBIO-TECHNE | 3.50% | $72.53 | +0.1% | ||
| 8 | VRTXVERTEX PHARMACEUTICALS | 3.25% | $505.64 | +0.7% | ||
| 9 | QGENQIAGEN NV | 3.23% | $44.79 | -1.9% | ||
| 10 | BMRNBIOMARIN PHARMACEUTICAL | 2.94% | $55.20 | -1.8% | ||
| 11 | CRSPCRISPR THERAPEUTICS AG | 2.71% | $52.35 | -3.1% | ||
| 12 | VCYTVERACYTE | 2.57% | $43.16 | -3.3% | ||
| 13 | BNTXBIONTECH SE | 2.49% | $95.25 | -0.5% | ||
| 14 | CAICaris Life Sciences | 2.44% | $27.10 | -1.3% | ||
| 15 | ARWRARROWHEAD PHARMACEUTICALS | 2.35% | $61.48 | -0.1% |
The full book, free with one sign-in.
Top 15 positions are open to everyone. Sign in once and every fund’s complete holdings — plus CSV export, watchlists, and flow alerts — unlock across the network.
Sign in to see all 41| 1 week | -2.8% |
| 1 month | +4.0% |
| 3 months | +14.6% |
| 6 months | +51.3% |
| YTD | +47.1% |
| 1 year | +63.8% |
| 3 years | — |
PRICE RETURN, DISTRIBUTIONS NOT REINVESTED
| 1 week | — |
| 1 month | — |
| 3 months | — |
| YTD | — |
| 1 year | — |
CREATION/REDEMPTION DOLLARS, DAILY RECORDS
The top holding is 9.5% of the book; the top ten carry 56%. Spread across 50+ names, it behaves like roughly 24 equally-weighted positions.
VOLATILITY & DRAWDOWN FROM THE DAILY TAPE · CONCENTRATION FROM THE LATEST DISCLOSED BOOK
| Most-traded holdings, options premium | Bullish | Bearish |
|---|---|---|
| LLY ELI LILLY | $43M | $44M |
| MRNA MODERNA | $32M | $26M |
| TWST TWIST BIOSCIENCE | $5M | $5M |
| BMY BRISTOL MYERS SQUIBB | $2M | $2M |
| NTRA NATERA | $1M | $3M |
TODAY’S OPTIONS PREMIUM IN THE FUND’S UNDERLYING NAMES
Due diligence cuts both ways. These funds sit on the same shelf and beat GNOM on at least one dimension that matters — the fee, the asset base, or where the money is going.
| Fund | Fee | Assets | Flow, 1M | The case | |
|---|---|---|---|---|---|
| IVV iShares Core S&P 500 ETF | 0.03% | $896.9B | +$19.2B | -47bp on fee · 10593× the assets · +$19.2B in over the month | Head-to-head |
| SPDW State Street SPDR Portfolio Developed World ex-US ETF | 0.03% | $41B | +$286M | -47bp on fee · 485× the assets · +$286M in over the month | Head-to-head |
| BBUS JPMorgan BetaBuilders U.S. Equity ETF | 0.02% | $9.6B | +$187M | -48bp on fee · 113× the assets · +$187M in over the month | Head-to-head |
| SPMD State Street SPDR Portfolio S&P 400 Mid Cap ETF | 0.03% | $18.4B | +$199M | -47bp on fee · 217× the assets · +$199M in over the month | Head-to-head |
| SPYG State Street SPDR Portfolio S&P 500 Growth ETF | 0.04% | $57.9B | +$717M | -46bp on fee · 683× the assets · +$717M in over the month | Head-to-head |